Skip to main content

People in the News: Oct 5, 2010

Premium

Signature Diagnostics has named Rainer Kramer as its chief business officer. Kramer formerly was vice president of corporate business development at Jerini, and before that he worked in research and business development at MorphoSys and at Amgen.


Integromics has appointed Michael McManus as its president and CEO.

McManus most recently led GenomeQuest's corporate marketing, strategic alliances, product marketing, and development efforts. He also served as vice president of business development for the BioSciences Group at Fujitsu Computer Systems, executive VP and COO at Anvil Informatics, and VP of marketing and business development at CambridgeSoft.


Asterand has appointed Dalia Cohen to the position of chief scientific officer. Cohen joins Asterand from Rosetta Genomics, where she also served as CSO.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.